CHARM Therapeutics raises $80 million in Series B financing to develop a menin inhibitor for AML.
Amount Raised
$80 Million
Round Type
Series B
LondonBiotechnologyHealthcareHealth CareInvestors
Description
CHARM Therapeutics has secured $80 million in Series B financing. The funds will be used to advance the development of a best-in-class menin inhibitor for acute myeloid leukemia (AML). This financing round underscores the commitment to addressing significant unmet needs in cancer treatment. The company aims to leverage this investment to enhance its research initiatives.
Quick answer
CHARM Therapeutics raised $80 Million in a Series B round, dated September 2, 2025. Investors: Nvidia, Khosla Ventures, F Prime, Orbimed, SR One and New Enterprise Associates. CHARM Therapeutics is based in London, England, United Kingdom.
- How much did CHARM Therapeutics raise?
- CHARM Therapeutics raised $80 Million in a Series B round on September 2, 2025.
- Who invested in CHARM Therapeutics?
- Nvidia, Khosla Ventures, F Prime, Orbimed, SR One and New Enterprise Associates are named as investors in this round.
- What does CHARM Therapeutics do?
- CHARM Therapeutics is discovering and developing small molecule medicines against difficult-to-drug targets with our proprietary 3D deep learning-enabled platform, DragonFold.
- Where is CHARM Therapeutics based and how big is it?
- CHARM Therapeutics is based in London, England, United Kingdom.
- Who are the decision-makers at CHARM Therapeutics?
- Fundz holds 1 contact at CHARM Therapeutics, including the Executive Officer, Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as CHARM Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- ISOThrive raised $8.1M on October 10, 2025.
- Kernal Biologics raised $48M (Funding Round) on October 7, 2025.
- ReCode Therapeutics raised $29M (Funding Round) on September 29, 2025.
- Aarvik Therapeutics raised an undisclosed amount (Seed) on September 29, 2025.
- Aspira Women’s Health raised $3M on September 16, 2025.
- Microbot Medical raised $25M on September 16, 2025.
Who to call at CHARM Therapeutics, and when
A new round usually means CHARM Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day CHARM Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CHARM Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CHARM Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment CHARM Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansCHARM Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.